Vaginal PRP injections are emerging as a promising treatment for female sexual health. Furthermore, a recent randomized controlled trial highlights the clinical potential of this regenerative therapy for premenopausal women. This pilot study examined how platelet-rich plasma (PRP) influences sexual function when researchers inject it into the distal anterior vaginal wall. Consequently, the findings suggest a significant improvement in overall sexual satisfaction and physiological response.
The Clinical Benefits of Vaginal PRP Injections
Specifically, the trial enrolled fifty-two sexually active participants without severe sexual dysfunction. The research team randomized these women into two groups, receiving either a PRP injection or a saline placebo. Moreover, the primary goal involved tracking changes in the Female Sexual Function Index (FSFI) over a six-month period. The results indicated that the PRP group experienced a much larger increase in total FSFI scores at the six-week mark. Furthermore, these improvements remained visible through the six-month follow-up session. Women treated with PRP demonstrated enhanced scores in categories like desire, arousal, and lubrication. However, the study noted that while subscale scores improved, the total FSFI score provided the most statistically significant data point for clinical success.
Patient Satisfaction and Safety Results
In addition to physiological metrics, the researchers utilized the Patient Global Impression of Improvement (PGI-I) scale. This tool measures how patients perceive their own recovery or enhancement after a procedure. Remarkably, nearly 70% of the women in the PRP group reported improved sexual function by the six-week mark. In contrast, the control group showed significantly lower satisfaction rates during the same timeframe. Furthermore, the high satisfaction level among the PRP group persisted throughout the entire six-month study duration. Most importantly, the trial recorded no serious adverse events among any of the participants. Therefore, this data supports the safety and tolerability of the procedure for healthy premenopausal women. Finally, clinicians may consider these injections as a viable non-surgical option for enhancing sexual wellness.
Frequently Asked Questions
Q1: What is the primary benefit of vaginal PRP injections according to this study?
The study found that these injections significantly improve total Female Sexual Function Index (FSFI) scores, enhancing overall sexual satisfaction and response in premenopausal women.
Q2: How quickly can patients expect to see results?
Participants in the clinical trial showed significant improvements in sexual function as early as six weeks after receiving the one-time PRP injection.
Q3: Are there any side effects associated with the procedure?
According to the recent trial, the research team reported no serious adverse events, suggesting that the treatment is generally safe and well-tolerated.
References
- Clarke B et al. Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A Randomized Controlled Trial. Obstet Gynecol. 2026 Mar 19. doi: 10.1097/AOG.0000000000006256. PMID: 41855531.
- Rosen R et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208.
- Padoa A et al. Platelet-rich plasma in gynecology: a review. Int Urogynecol J. 2021;32(11):2845-2853.